Cizmeda Trademark Details

This mark is alive with a status of New Application - Record Initialized Not Assigned to Examiner. The last case file activity for this mark occured 7 years ago on Tuesday, August 23, 2016, according to the United State Patent & Trademark Office
Word Mark Cizmeda
Status Alive 630 — New Application - Record Initialized Not Assigned to Examiner

Current Owner

Celgene Corporation of Summit, NJ

View all trademarks for Celgene Corporation
Other Trademarks for Celgene Corporation
Serial Number 87143183
Status Date Tuesday, August 23, 2016
Filing Date Tuesday, August 23, 2016
Attorney Camille M. Miller

Correspondent

CAMILLE M. MILLER
COZEN O'CONNOR
1650 MARKET STREET
SUITE 2800
PHILADELPHIA, PA 19103

Case File Statements

Goods & Services Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, August 23, 2016
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.